Skip to main content
SpringerLink
Log in

Evidence of p53-induced apoptosis in cancer cells exposed to taxol

  • Letter To The Editor
  • Scientific Reports
  • Published:
In Vitro Cellular & Developmental Biology - Animal Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Bhalla, K.; Ibrado, A. M.; Toukina, E., et al. Taxol induces internucleosomal DNA fragmentation associated with programmed cell death in human myeloid leukemia cells. Leukemia 7:563–568; 1993.

    PubMed  CAS  Google Scholar 

  2. Chuang, L. T.; Lotzova, E.; Heath, J., et al. Alteration of lymphocyte microtubule assembly, cytotoxicity, and activation by the anticancer drug taxol. Cancer Res. 54:1286–1291; 1994.

    PubMed  CAS  Google Scholar 

  3. Donaldson, K. L.; Goolsby, G. L.; Wahl, A. F. Cytotoxicity of the anticancer agents cisplatin and taxol during cell proliferation and the cell cycle. Int. J. Cancer 57:847–855; 1994.

    Article  PubMed  CAS  Google Scholar 

  4. Fernandez, P.; Rotello, R.; Rangini, Z., et al. Expression of a specific marker of avian programmed cell death in both apoptosis and necrosis. Proc. Natl. Acad. Sci. USA 91:8652–8655; 1994.

    Article  Google Scholar 

  5. Fujiwara, T. F.; Grimm, E. A.; Mukhopadhyay, T., et al. A retroviral wild-type p53 expression vector penetrates human lung cancer spheroids and inhibits growth by inducing apoptosis. Cancer Res. 53:4129–4133; 1993.

    PubMed  CAS  Google Scholar 

  6. Gangemi, R. M. R.; Tiso, M.; Marchetti, C., et al. Taxol cytotoxicity on human leukemia cell lines is a function of their susceptibility to programmed cell death. Cancer Chemother. Pharmacol. 36:385–392; 1995.

    PubMed  CAS  Google Scholar 

  7. Ho, Y.; Wang, Y.; Lin, J. Induction of p53 and p21/WAF1/CIP1 expression by nitric oxide and their association with apoptosis in human cancer cells. Mol. Carcinog. 16:20–31; 1996.

    Article  PubMed  CAS  Google Scholar 

  8. Majumdar, S. K.; Andreassi, J.; Metzger, M., et al. Response of murine erythroleukemia cells to the anticancer drug, taxol. Cell Biol. Int. 480:565; 1994.

    Google Scholar 

  9. Majumdar, S. K.; Bachman, C. Evidence of apoptosis and necrosis in taxol treated murine erythroleukemia cells. Mol. Biol. Cell 7:194a; 1996.

    Google Scholar 

  10. Majumdar, S. K.; Welchel, B.; Bachman, C. Evidence of p53-dependent toxicity of taxol, an anti-cancer drug, on cultured murine erythroleukemia cells. In Vitro Cell. Dev. Biol. 32:62A-63A; 1996.

    Google Scholar 

  11. Milas, L.; Hunter, N. R.; Kurdoglu, B., et al. Kinetics of mitotic arrest and apoptosis in murine mammary and ovarian tumors treated with taxol. Cancer Chemother. Pharmacol. 35:297–303; 1995.

    PubMed  CAS  Google Scholar 

  12. Milas, L.; Stephens, L. C.; Meyn, R. E. Relation of apoptosis to cancer therapy. In Vivo 8:665–674; 1994.

    PubMed  CAS  Google Scholar 

  13. Oncogene Research Products. Wild-type p53-activated fragment ELISA product sheet. Cambridge, MA: 1996.

  14. Rowinsky, E. K.; Donehower, R. C.; Tucker, R. W. Microtubule changes and cytotoxicity in leukemic cell lines treated with taxol. Cancer Res. 48:4093–4099; 1988.

    PubMed  CAS  Google Scholar 

  15. Ryan, J. J.; Clarke, M. F. Alteration of p53 conformation and induction of apoptosis in a murine erythroleukemia cell line by dimethylsulf-oxide. Leuk. Res. 18:617–621; 1994.

    Article  PubMed  CAS  Google Scholar 

  16. Schwartz, L.; Smith, S.; Jones, M., et al. Do all programmed cell deaths occur via apoptosis? Proc. Natl. Acad. Sci. USA. 90:980–984; 1993.

    Article  PubMed  CAS  Google Scholar 

  17. Seiter, K.; Feldman, E. J.; Traganos, F., et al. Evaluation of in vivo induction of apoptosis in patients with acute leukemia treated on a phase I study of paclitaxel. Leukemia 9:1961–1983; 1995.

    PubMed  CAS  Google Scholar 

  18. Speicher, L. A.; Barone, L.; Tew, K. D. Combined antimicrotubule activity of estramustine and taxol in human prostatic carcinoma lines. Cancer Res. 52:4433–4440; 1992.

    PubMed  CAS  Google Scholar 

  19. Tishler, R. B.; Lamppu, D. M.; Park, S., et al. Microtubule-active drugs taxol, vinblastine, and nocodazole increase the levels of transcriptionally active p53. Cancer Res. 55:6021–6025; 1995.

    PubMed  CAS  Google Scholar 

  20. Trauth, B. C.; Wittor, H.; Rubmann, E. Two non-radioactive immunoassays for the measurement of apoptotic cell death. Indianapolis, IN: Boehringer Mannheim Biochemicals; 1994.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Biology, Lafayette College, 18042, Easton, Pennsylvania

    Chari A. Bachman, Daniel A. Bills & Shyamal K. Majumdar

Authors
  1. Chari A. Bachman
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Daniel A. Bills
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Shyamal K. Majumdar
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bachman, C.A., Bills, D.A. & Majumdar, S.K. Evidence of p53-induced apoptosis in cancer cells exposed to taxol. In Vitro Cell.Dev.Biol.-Animal 34, 434–435 (1998). https://doi.org/10.1007/s11626-998-0072-3

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11626-998-0072-3

Keywords

Search

Navigation